Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Simó Schwartz

Showing results (61-70 of 69) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 69 results.
Journal of Controlled Release : Official Journal of the Controlled Release Society|December 9, 2025
Corrigendum to 'Preclinical evaluation of several polymeric micelles identifies Soluplus®-docetaxel as the most effective candidate in multiple glioblastoma models' [Journal of Controlled Release (2025) 381:113616]Júlia German-Cortés, Raquel Herrero, Natalia Torroglosa, et al.
Journal of Extracellular Vesicles|March 19, 2021
Extracellular vesicles from recombinant cell factories improve the activity and efficacy of enzymes defective in lysosomal storage disordersJoaquin Seras-Franzoso, Zamira V Díaz-Riascos, José Luis Corchero, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|March 12, 2025
Preclinical evaluation of several polymeric micelles identifies Soluplus®-docetaxel as the most effective candidate in multiple glioblastoma modelsJúlia German-Cortés, Raquel Herrero, Natalia Torroglosa, et al.
Molecular Cancer|October 22, 2014
SPARC mediates metastatic cooperation between CSC and non-CSC prostate cancer cell subpopulationsFrancesca Mateo, Oscar Meca-Cortés, Toni Celià-Terrassa, et al.
Human Molecular Genetics|December 4, 2009
Mixed lineage kinase 3 gene mutations in mismatch repair deficient gastrointestinal tumoursSérgia Velho, Carla Oliveira, Joana Paredes, et al.
ACS Applied Materials & Interfaces|January 2, 2025
Preclinical Development of Magnetic Nanoparticles for Hyperthermia Treatment of Pancreatic CancerZamira V Díaz-Riascos, Monserrat Llaguno-Munive, Nuria Lafuente-Gómez, et al.
Science Advances|December 13, 2024
Targeted nanoliposomes to improve enzyme replacement therapy of Fabry diseaseJudit Tomsen-Melero, Marc Moltó-Abad, Josep Merlo-Mas, et al.
The Journal of Supercritical Fluids|July 5, 2021
Application of Quality by Design to the robust preparation of a liposomal GLA formulation by DELOS-susp methodJosep Merlo-Mas, Judit Tomsen-Melero, José-Luis Corchero, et al.
ACS Applied Materials & Interfaces|February 15, 2021
Impact of Chemical Composition on the Nanostructure and Biological Activity of α-Galactosidase-Loaded Nanovesicles for Fabry Disease TreatmentJudit Tomsen-Melero, Solène Passemard, Natalia García-Aranda, et al.
Pageof 7

Showing results (61-70 of 69) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 69 results.
Journal of Controlled Release : Official Journal of the Controlled Release Society|December 9, 2025
Corrigendum to 'Preclinical evaluation of several polymeric micelles identifies Soluplus®-docetaxel as the most effective candidate in multiple glioblastoma models' [Journal of Controlled Release (2025) 381:113616]Júlia German-Cortés, Raquel Herrero, Natalia Torroglosa, et al.
Journal of Extracellular Vesicles|March 19, 2021
Extracellular vesicles from recombinant cell factories improve the activity and efficacy of enzymes defective in lysosomal storage disordersJoaquin Seras-Franzoso, Zamira V Díaz-Riascos, José Luis Corchero, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|March 12, 2025
Preclinical evaluation of several polymeric micelles identifies Soluplus®-docetaxel as the most effective candidate in multiple glioblastoma modelsJúlia German-Cortés, Raquel Herrero, Natalia Torroglosa, et al.
Molecular Cancer|October 22, 2014
SPARC mediates metastatic cooperation between CSC and non-CSC prostate cancer cell subpopulationsFrancesca Mateo, Oscar Meca-Cortés, Toni Celià-Terrassa, et al.
Human Molecular Genetics|December 4, 2009
Mixed lineage kinase 3 gene mutations in mismatch repair deficient gastrointestinal tumoursSérgia Velho, Carla Oliveira, Joana Paredes, et al.
ACS Applied Materials & Interfaces|January 2, 2025
Preclinical Development of Magnetic Nanoparticles for Hyperthermia Treatment of Pancreatic CancerZamira V Díaz-Riascos, Monserrat Llaguno-Munive, Nuria Lafuente-Gómez, et al.
Science Advances|December 13, 2024
Targeted nanoliposomes to improve enzyme replacement therapy of Fabry diseaseJudit Tomsen-Melero, Marc Moltó-Abad, Josep Merlo-Mas, et al.
The Journal of Supercritical Fluids|July 5, 2021
Application of Quality by Design to the robust preparation of a liposomal GLA formulation by DELOS-susp methodJosep Merlo-Mas, Judit Tomsen-Melero, José-Luis Corchero, et al.
ACS Applied Materials & Interfaces|February 15, 2021
Impact of Chemical Composition on the Nanostructure and Biological Activity of α-Galactosidase-Loaded Nanovesicles for Fabry Disease TreatmentJudit Tomsen-Melero, Solène Passemard, Natalia García-Aranda, et al.
Pageof 7